NCT01142362View on ClinicalTrials.gov

Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy
Interventions
BIOLOGICAL

VGX-3400X

DNA plasmids delivered via IM injection + electroporation using CELLECTRA device

Trial Locations (2)

20850

Accelovance, Rockville

66212

Vince & Associates, Overland Park

Sponsors
All Listed Sponsors
lead

Inovio Pharmaceuticals

INDUSTRY